South Korean giant's biotech arm to make $35M investment in Irish facility
Amidst a hail of investments coming from South Korean conglomerates into biotech, including Lotte and Samsung, SK is looking to get in on the action.
SK Pharmteco, a CDMO and subsidiary of the second-largest conglomerate in South Korea, is investing $35 million to expand SK’s pharmaceutical manufacturing plant in the Dublin suburb of Swords, Ireland, including a new building.
According to SK, the expansion project will provide an increase in the site’s manufacturing capacity and capabilities, coming online sometime in 2024.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.